NurExone Biologic Inc.: James Richardson, the Former CEO of EnerSpar, Updates Shareholders After the Completion of RTO with NurExone Biologic

Calgary, Alberta--(Newsfile Corp. - August 9, 2022) - NurExone Biologic Inc. (TSXV: NRX) (formerly, EnerSpar Corp.) (the "Company" or "NurExone"), a biopharmaceutical company developing biologically-guided

Related Keywords

United States ,Israel ,America ,Lior Shaltiel ,Nurexone Exotherapy ,Eli Lilly ,Jay Richardson ,Medigus Ltd ,Enerspar Corp The Company Or Nurexone ,Polyrizon Ltd ,Technion University ,Evox Therapeutics Ltd ,Nurexone Biologic Inc ,Israel Institute Of Technology ,Alberta Newsfile Corp ,Research Agreement ,Exone Biologic ,Enerspar Corp ,North America ,Sponsor Research Agreement ,Collaboration Agreement ,Israel Institute ,Executive Officer ,Nurexone ,Biologic ,Games ,Richardson ,Former ,Enerspar ,Updates ,Shareholders ,After ,Completion ,